Document Detail

C-kit-positive cardiac stem cells and myocardial regeneration.
MedLine Citation:
PMID:  22254215     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Two distinct subpopulations of endogenous cardiac stem cells (CSCs) are identified in the adult heart; myogenic CSCs (mCSCs), which are characterized by the presence of c-kit receptor, reside in the myocyte niche surrounded by matured cardiomyocytes, whereas vasculogenic CSCs (vCSCs), which express c-kit as well as KDR, are stored in the vascular niche found in the vessel wall. They both possess the fundamental properties of stem cells: self -renewing, clonogenic, and multipotent. While mCSCs preferentially differentiate into myocyte lineage in vitro, vCSCs tend to commit to vascular endothelial or smooth muscle lineages upon stimulation. Intramyocardial injection of human mCSCs to the region bordering infarct of immunosuppressed animals induces cardiac regeneration involving intensive muscle and vessel formation. On the other hand, the administration of human vCSCs near the critical stenosis created in the dog coronary artery results in the formation of large conductive vessels, i.e. "biological coronary bypass", coupled with the improved tissue perfusion. A clinical trial utilizing autologous c-kit-positive CSCs on patients with chronic ischemic heart failure was launched recently. Upon coronary artery bypass graft (CABG) surgery, a small portion of the right atrial appendage was obtained and used for isolation and expansion of CSCs. Intracoronary CSC implantation was performed 4 months after the surgery, and the symptom and the cardiac function were followed. Although the study is still ongoing, no adverse event due to cell infusion has been reported in any of the cell-treated patients, and the initial outcome is very promising. Disease-based customized cell therapy employing various combinations of autologous mCSCs and vCSCs would become available in the near future.
Toru Hosoda
Related Documents :
17081085 - Use of the ace inhibitor zofenopril in the treatment of ischemic heart disease.
20977405 - Sumatriptan therapy for headache and acute myocardial infarction.
18971565 - Absence of outcome difference in elderly patients with and without dementia after acute...
12455085 - Platelet glycoprotein iib/iiia inhibition using eptifibatide with primary coronary sten...
6851275 - Unusual cardiovascular manifestations in a case of pheochromocytoma.
15733315 - Acute st-segment elevation myocardial infarction after amoxycillin-induced anaphylactic...
Publication Detail:
Type:  Journal Article     Date:  2011-12-15
Journal Detail:
Title:  American journal of cardiovascular disease     Volume:  2     ISSN:  2160-200X     ISO Abbreviation:  Am J Cardiovasc Dis     Publication Date:  2012  
Date Detail:
Created Date:  2012-01-18     Completed Date:  2012-10-02     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101569582     Medline TA:  Am J Cardiovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  58-67     Citation Subset:  -    
Tokai University Institute of Innovative Science and Technology 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new.
Next Document:  Long-term results of the amplatzer cribriform occluder for patent foramen ovale with associated atri...